Leonard Schleifer

Co-founder, President and CEO, Regeneron

Tarrytown, New York

About

Leonard Schleifer, M.D., Ph.D., is the founder, president and chief executive officer of Regeneron Pharmaceuticals and co-chair of its board. He founded the company in 1988 and has led it as CEO since then. A Regeneron filing with the SEC dated 24 September 2026 identifies him as board co-chair, president and chief executive officer. The company is based in Tarrytown, New York.

Schleifer earned a bachelor's degree from Cornell University and an M.D. and Ph.D. in pharmacology from the University of Virginia. He is a licensed physician certified in neurology and trained in neurology at New York Hospital before founding Regeneron. He chaired the board from 1990 to 1994 and has been co-chair since 2023. Whoo also has pages for other biopharma chief executives: David Ricks of Eli Lilly, Robert Bradway of Amgen and Chris Boerner of Bristol Myers Squibb.

Whoo compiled this page from public sources: Wikipedia, Regeneron 2026 proxy statement (SEC), Regeneron Form 8-K, 24 September 2026 (SEC). It is not affiliated with or endorsed by Leonard Schleifer. Are you Leonard Schleifer? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17.

Want a page like this? Create yours from your résumé.

Experience

Co-founder, President and Chief Executive Officer — Regeneron Pharmaceuticals


1988 – Present | Tarrytown, New York

  • Board co-chair since 2023; chair of the board from 1990 to 1994
  • Neurology trainee and junior faculty member — New York Hospital

  • Trained in neurology before founding Regeneron

Education

MD and PhD in Pharmacology — University of Virginia

BS — Cornell University

Projects